From Seekingalpha · SA Transcripts · · 40s
Indutrade Q3 2026 Earnings Highlights
Indutrade AB reported 13% net sales growth and 6% organic expansion in Q3 2026.
In brief
Indutrade AB reported 13% net sales growth and 6% organic expansion in Q3 2026. Indutrade AB achieved 13% net sales growth and 6% organic expansion in Q3 2026 with strong MedTech and Pharma demand. Originally reported by Seekingalpha.
Q3 2026 Results
Indutrade AB reported 13% net sales growth and 6% organic expansion in Q3 2026.
Strong Demand in MedTech and Pharma
Demand improved for companies with customers in MedTech and Pharma, driving 6% organic growth.
Acquisitions and Cash Flow
13 acquisitions announced this year with EBITA margin rising from 14.6% to 15.3% and cash flow up 20%.
What matters most
Indutrade AB achieved 13% net sales growth and 6% organic expansion in Q3 2026 with strong MedTech and Pharma demand.
